Use of microarrays in the search of gene expression patterns - Application to the study of complex phenotypes;Uso de microarrays na busca de perfis de expressão gênica - Aplicação no estudo de fenótipos complexos

Revista Brasileira de Psiquiatria

Volumn 29, Issue 4, 2007, Pages 370-374

  Guindalini, Camila ^a   Tufik, Sergio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gene expression; Mental disorders; Microarray analysis; Psychiatry; Sleep deprivation

Indexed keywords

DNA;

ARTICLE; BIOASSAY; DNA MICROARRAY; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; MEDICAL TECHNOLOGY; MENTAL DISEASE; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; PHENOTYPE; SLEEP DISORDER; ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; REVIEW; SLEEP DEPRIVATION; THEORETICAL MODEL; NONHUMAN;

ANIMALS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; MENTAL DISORDERS; MICROARRAY ANALYSIS; MODELS, THEORETICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; SLEEP DEPRIVATION;

EID: 38349093882     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-44462007000400014     Document Type: Article

References (41)

1. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004;431(7011):931-45.
2. Davis RL, Khoury MJ. A public health approach to pharmacogenomics and gene-based diagnostic tests. Pharmacogenomics. 2006;7(3):331-7.
3. Mocellin S, Rossi CR. Principles of gene microarray data analysis. Adv Exp Med Biol. 2007;593:19-30.
4. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotech. 1996;14(13):1675-80.
5. Sharp FR, Xu H, Lit L, Walker W, Apperson M, Gilbert DL, Glauser TA, Wong B, Hershey A, Liu DZ, Pinter J, Zhan X, Liu X, Ran R. The future of genomic profiling of neurological diseases using blood. Arch Neurol. 2006;63(11):1529-36.
6. Dalma-Weiszhausz DD, Warrington J, Tanimoto EY, Miyada CG. The affymetrix GeneChip platform: an overview. Methods Enzymol. 2006;410:3-28.
7. Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R, Childs G. Making and reading microarrays. Nat Genet. 1999;21(1 Suppl):15-9.
8. Staudt LM, Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol. 2005;87:163-208.
9. Cowell JK, Hawthorn L. The application of microarray technology to the analysis of the cancer genome. Curr Mol Med. 2007;7(1):103-20.
10. Pahl A, Benediktus E, Chialda L. Pharmacogenomics of asthma. Curr Pharm Des. 2006;12(25):3195-206.
11. Mirnics K, Levitt P, Lewis DA. Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry. 2006;60(2):163-76.
12. Nanni L, Romualdi C, Maseri A, Lanfranchi G. Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. J Mol Cell Cardiol. 2006;41(6):934-48.
13. Mills JC, Roth KA, Cagan RL, Gordon JI. DNA microarrays and beyond: completing the journey from tissue to cell. Nat Cell Biol. 2001;3(8):E175-8.
14. Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(3):559-76.
15. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 2000;28(1):53-67.
16. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG, Freed WJ. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res. 2002;58(1):11-20.
17. Hemby SE, Ginsberg SD, Brunk B, Arnold SE, Trojanowski JQ, Eberwine JH. Gene expression profile for schizophrenia: Discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry. 2002;59(7):631-40.
18. Thompson PM, Egbufoama S, Vawter MP. SNAP-25 reduction in the hippocampus of patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(3):411-7.
19. Vawter MP, Thatcher L, Usen N, Hyde TM, Kleinman JE, Freed WJ. Reduction of synapsin in the hippocampus of patients with bipolardisorder and schizophrenia. Mol Psychiatry. 2002;7(6):571-8.
20. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry. 1999;45(1):17-25.
21. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Biol Psychiatry. 2000;57(1):65-73.
22. Aston C, Jiang L, Sokolov BP. Microarray analysis of post-mortem temporal cortex from patients with schizophrenia. J Neurosci Res. 2004;77(6):858-66.
23. Sugai T, Kawamura M, Iritani S, Araki K, Makifuchi T, Imai C, Nakamura R, Kakita A, Takahashi H, Nawa H. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Ann N Y Acad Sci. 2004;1025:84-91.
24. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003;362(9386):798-805.
25. Iwamoto K, Bundo M, Kato T. Altered expression of mitochondria related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet. 2005;14(2):241-53.
26. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci. 2002;22(7):2718-29.
27. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. 2004;9(7):684-97, 643.
28. Konradi C, Heckers S. Molecular aspects of glutamate dysregulation: Implications for schizophrenia and its treatment. Pharmacol Ther. 2003;97(2):153-79.
29. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood WH 3rd, Donovan DM, Webster M, Freed WJ, Becker KG. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull. 2001;55(5):641-50.
30. Pilcher JJ, Huffcutt AI. Effects of sleep deprivation on performance: a meta-analysis. Sleep. 1996;19(4):318-26.
31. Leonard C, Fanning N, Attwood J, Buckley M. The effect of fatigue, sleep deprivation and onerous working hours on the physical and mental well being of pre-registration house officers. Ir J Med Sci. 1998;167(1):22-5.
32. Freidman J, Globus G, Huntley A, Mullaney D, Naitoh P, Johnson L. Performance and mood during and after gradual sleep reduction. Psychophysiology. 1977;14(3):245-50.
33. Naitoh P, Kelly TL, Englund C. Health effects of sleep deprivation. Occup Med. 1990;5(2):209-37.
34. Boivin DB. Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. J Psychiatry Neurosci. 2000;25(5):446-58.
35. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262(11):1479-84.
36. Cirelli C, Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res. 2000;885(2):303-21.
37. Cirelli C, Faraguna U, Tononi G. Changes in brain gene expression after long-term sleep deprivation. J Neurochem. 2006;98(5):1632-45.
38. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006;166(16):1756-62.
39. Palma BD, Tiba PA, Machado RB, Tufik S, Suchecki D. Immune outcomes of sleep disorders: the hypothalamic-pituitary-adrenal axis as a modulatory factor. Rev Bras Psiquiatr. 2007;29(Suppl 1):S33-8.
40. Debouck C, Goodfellow PN. DNA microarrays in drug discovery and development. Nat Genet. 1999;21(1 Suppl):48-50.
41. Dupuy A, Simon RM. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst. 2007;99(2):147-57.